| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
27,672 |
25,757 |
$2.68M |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
7,199 |
6,899 |
$513K |
| 99215 |
Prolong outpt/office vis |
4,312 |
4,180 |
$512K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
14,535 |
14,387 |
$335K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
20,345 |
20,175 |
$278K |
| 92552 |
|
12,977 |
12,942 |
$251K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
4,495 |
4,492 |
$237K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
3,383 |
3,379 |
$216K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
3,251 |
3,241 |
$149K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
1,441 |
1,427 |
$64K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
1,203 |
1,193 |
$47K |
| 85018 |
|
16,585 |
16,547 |
$42K |
| D1206 |
Topical application of fluoride varnish |
2,445 |
2,422 |
$42K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
2,706 |
2,651 |
$32K |
| 81002 |
|
10,945 |
10,652 |
$30K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
1,868 |
958 |
$26K |
| 87650 |
|
1,841 |
1,811 |
$22K |
| 99173 |
|
12,869 |
12,839 |
$22K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
883 |
875 |
$16K |
| 94760 |
|
4,027 |
3,785 |
$16K |
| 0072A |
|
175 |
164 |
$6K |
| 0071A |
|
176 |
160 |
$6K |
| 99188 |
|
326 |
323 |
$5K |
| 99383 |
|
159 |
159 |
$5K |
| 99395 |
Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years |
42 |
42 |
$4K |
| 69210 |
|
98 |
98 |
$4K |
| 99384 |
|
64 |
64 |
$3K |
| 99000 |
|
657 |
645 |
$2K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
121 |
118 |
$2K |
| 83655 |
|
155 |
154 |
$2K |
| 99381 |
|
14 |
13 |
$2K |
| 90651 |
|
1,500 |
1,499 |
$2K |
| 81003 |
|
899 |
891 |
$2K |
| 90686 |
|
5,238 |
5,236 |
$729.64 |
| 0154A |
|
14 |
14 |
$560.00 |
| 99382 |
|
14 |
14 |
$432.24 |
| 90670 |
|
1,147 |
1,135 |
$424.45 |
| 94664 |
|
29 |
28 |
$351.16 |
| 90619 |
|
312 |
312 |
$350.00 |
| 90734 |
|
762 |
762 |
$187.49 |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
599 |
594 |
$165.60 |
| 90716 |
|
205 |
205 |
$139.45 |
| 90698 |
|
1,105 |
1,096 |
$121.68 |
| 90700 |
|
150 |
147 |
$107.68 |
| 90707 |
|
123 |
123 |
$90.56 |
| A7015 |
Aerosol mask, used with dme nebulizer |
52 |
51 |
$81.91 |
| 90648 |
|
112 |
109 |
$78.55 |
| 99401 |
|
13 |
13 |
$64.17 |
| 90715 |
|
495 |
495 |
$54.84 |
| 90633 |
|
1,033 |
1,030 |
$37.80 |
| 90744 |
|
588 |
580 |
$31.45 |
| 90688 |
|
166 |
166 |
$23.80 |
| J7620 |
Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme |
64 |
63 |
$6.10 |
| J7613 |
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg |
25 |
25 |
$2.95 |
| 90710 |
|
375 |
374 |
$0.00 |
| 90461 |
|
172 |
172 |
$0.00 |
| 90671 |
|
332 |
332 |
$0.00 |
| 90713 |
|
46 |
46 |
$0.00 |
| 90661 |
|
213 |
213 |
$0.00 |
| 90685 |
|
14 |
14 |
$0.00 |
| 90696 |
|
311 |
310 |
$0.00 |
| 90680 |
|
419 |
418 |
$0.00 |
| 91307 |
|
82 |
82 |
$0.00 |
| 96161 |
|
12 |
12 |
$0.00 |